Overview
Pamela Riemer practices practicing medicine in Berlin, Germany.
Her clinical expertise encompasses Neuroendocrine Tumor, PIK3CA-Related Overgrowth Spectrum, and Colorectal Cancer.
She is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Pamela Riemer
Is Pamela Riemer a top-rated expert for Neuroendocrine Tumor?
MediFind is an objective health platform that identifies experts based on real-world data. Pamela Riemer is classified as an Experienced expert for Neuroendocrine Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Pamela Riemer participate in research or clinical trials?
Yes. Pamela Riemer has published 14 articles and abstracts on conditions like Neuroendocrine Tumor. You can view a list of Pamela Riemer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Colorectal CancerMs. Riemer isExperienced. Learn about Colorectal Cancer.
- Neuroendocrine TumorMs. Riemer isExperienced. Learn about Neuroendocrine Tumor.
- PIK3CA-Related Overgrowth SpectrumMs. Riemer isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.